News
New technique for synthesizing branched molecules could accelerate the development of future medicines
9+ hour, 17+ min ago (242+ words) Scripps Research chemists solve a longstanding problem in the construction of branched molecular frameworks, unlocking a faster path to the complex structures found in drugs and materials. "This work solves a selectivity problem that challenged us for years," says Ryan…...
Top Players and Competitive Overview in the Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market
3+ hour, 51+ min ago (68+ words) open PR. com Top Players and Competitive Overview in the Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Press release from: The Business Research Company Permanent link to this press release: You can edit or delete your press release Top…...
STROKE STUDY: UF researcher finds enzyme that might boost brain after stroke
6+ hour, 7+ min ago (633+ words) TAMPA" In the race to limit brain damage after a stroke, most treatments try to block harmful processes. According to a news release, a University of Florida Health researcher is pursuing a different strategy: boosting the brain's own protective machinery....
KAIST and Nobel Laureate Design AI Protein for Precision Medicine
3+ hour, 14+ min ago (7+ words) AI-Designed Artificial Protein Targets Disease Substances...
Chiba University study flags allergy risk in high-binding antibody drugs
1+ day, 1+ hour ago (177+ words) For the biopharma industry, the study strengthens the case for balancing immune-cell engagement with tolerability in antibody discovery platforms The study found that'antibody therapeutics with stronger binding affinity to Fc" receptors on immune cells were significantly more likely to induce…...
Yaosu Technology Secures RMB 200 M in Financing: Integrating "AI + Organ-on-a-Chip" into New Drug Development Process
10+ hour, 34+ min ago (236+ words) Text | Hu Xiangyun Editor | Hai Ruojing The pharmaceutical industry is one step closer to "saying goodbye" to animal testing. Image source: FDA official website Previously, one of the major doubts about organoid/organ-on-a-chip companies in the pharmaceutical industry was whether…...
Scientists Use AI to Design and Patent Cortisol-Sensing Protein
7+ hour, 37+ min ago (283+ words) Artificial protein that recognizes the stress hormone cortisol enables a novel biosensor. A KAIST research team, in collaboration with the 2024 Nobel laureate in Chemistry, Professor David Baker of the University of Washington, has successfully used artificial intelligence (AI) to design,…...
Immutep reassesses and resets lead cancer program following trial setback
13+ hour, 42+ min ago (218+ words) Immutep (ASX: IMM) recently announced the discontinuation of its Phase 3 TACTI-004 study in first-line non-small cell lung cancer, following an interim futility analysis that showed patients receiving its lead candidate underperformed the control arm. The decision, guided by the Independent Data…...
FDA Accepts First AI-Based Neuroscience Drug-Development Tool
17+ hour, 1+ min ago (147+ words) the content of the qualification plan, the evidence-generation and validation strategy the FDA requires, and any published guidance or qualification documentation in the CDER & CBER Drug Development Tool Qualification Project Search. These artifacts will set practical expectations for data collection,…...
Study outlines principles for using CAR immunotherapies to treat neurodegenerative diseases
19+ hour, 43+ min ago (730+ words) News-Medical Study outlines principles for using CAR immunotherapies to treat neurodegenerative diseases A UAB research team defines the criteria that CAR immunotherapies for neurodegenerative diseases must meet to advance both conceptually and in trials, which are still at a very…...